Compounds > cresidine
Page last updated: 2024-08-18

cresidine and Bladder Cancer

cresidine has been researched along with Bladder Cancer in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's3 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alvord, WG; Barrett, JC; Beltran, L; DiGiovanni, J; Haines, DC; Hill, HL; Hursting, SD; Lavigne, JA; Perkins, SN1
Braun, AG; Rao, GN; Russfield, A; Seilkop, S; Tennant, RW1
Barrett, JC; Dunn, SE; French, J; Kari, FW; Leininger, JR; Travlos, G; Wilson, R1
Dunnick, JK; French, JE; Hulla, JE1
Dunnick, JK; Foley, J; French, JE; Lacks, GD; Mahler, J; Tennant, RW; Tice, RR; Trempus, C1
Bolcsfoldi, G; Hellmér, L1

Other Studies

6 other study(ies) available for cresidine and Bladder Cancer

ArticleYear
Urothelial overexpression of insulin-like growth factor-1 increases susceptibility to p-cresidine-induced bladder carcinogenesis in transgenic mice.
    Molecular carcinogenesis, 2009, Volume: 48, Issue:8

    Topics: Aniline Compounds; Animals; Carcinoma, Transitional Cell; Cattle; Female; Humans; Insulin-Like Growth Factor I; Keratin-5; Mice; Mice, Transgenic; Papilloma; Promoter Regions, Genetic; Urinary Bladder; Urinary Bladder Neoplasms

2009
Chemical effects in transgenic mice bearing oncogenes expressed in mammary tissue.
    Carcinogenesis, 1993, Volume: 14, Issue:1

    Topics: Adenocarcinoma; Aniline Compounds; Animals; Carcinogens; Female; Gene Expression; Genes, myc; Genes, ras; Male; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mammary Tumor Virus, Mouse; Mice; Mice, Transgenic; Oncogenes; Proto-Oncogene Proteins; Receptor, ErbB-2; Reserpine; Survival Analysis; Urinary Bladder Neoplasms

1993
Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice.
    Cancer research, 1997, Nov-01, Volume: 57, Issue:21

    Topics: Aniline Compounds; Animals; Apoptosis; Carcinogens; Carcinoma, Transitional Cell; Cell Division; Disease Progression; Hyperplasia; Incidence; Insulin-Like Growth Factor I; Male; Mice; Mice, Transgenic; Neoplasm Staging; Precancerous Conditions; Urinary Bladder; Urinary Bladder Neoplasms; Urothelium

1997
Chromosome 11 allelotypes reflect a mechanism of chemical carcinogenesis in heterozygous p53-deficient mice.
    Carcinogenesis, 2001, Volume: 22, Issue:1

    Topics: Alleles; Aniline Compounds; Animals; Benzene; Carcinogenicity Tests; Carcinogens; Chromosomes; Crosses, Genetic; DNA, Neoplasm; Female; Genes, p53; Heterozygote; Loss of Heterozygosity; Lymphoma; Male; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Phenolphthalein; Polymorphism, Genetic; Sarcoma, Experimental; Thymus Neoplasms; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms

2001
Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent.
    Carcinogenesis, 2001, Volume: 22, Issue:1

    Topics: Alleles; Aniline Compounds; Animals; Bacterial Proteins; Benzene; Carcinogens; Escherichia coli Proteins; Female; Genes, p53; Lac Repressors; Loss of Heterozygosity; Lymphoma; Male; Mice; Mice, Inbred C57BL; Mutagenesis; Neoplasms, Experimental; Phenolphthalein; Polymorphism, Single-Stranded Conformational; Repressor Proteins; Sarcoma, Experimental; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms

2001
Comments on the paper 'The non-genotoxicity to rodents of the potent bladder carcinogens o-anisidine and p-cresidine'.
    Mutation research, 1992, Jun-01, Volume: 279, Issue:3

    Topics: Aniline Compounds; Animals; Carcinogens; Mice; Mutagens; Urinary Bladder Neoplasms

1992